Research ArticleCardiology

Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarction

See allHide authors and affiliations

Science Translational Medicine  01 Jan 2020:
Vol. 12, Issue 524, eaay2140
DOI: 10.1126/scitranslmed.aay2140

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Straightening up scars

As a result of myocardial infarction (MI; heart attack), scar tissue forms that negatively affects cardiac function. Thavapalachandran et al. investigated the potential therapeutic effects of intravenous delivery of recombinant human platelet-derived growth factor-AB (rhPDGF-AB) after MI in a randomized, double-blinded study in pigs. Cardiac function was improved 28 days after treatment was initiated and rhPDGF-AB enhanced angiogenesis; however, there was no difference in the size of scars between rhPDGF-AB–treated and vehicle-treated pigs. Scars in rhPDGF-AB–treated pigs showed less heterogeneity and greater fiber alignment, and rhPDGF-AB–treated pigs were less susceptible to arrhythmia after MI. Results support the translational potential of rhPDGF-AB to modulate scars and augment cardiac repair.

View Full Text

Stay Connected to Science Translational Medicine

Editor's Blog